Minimally Invasive Brain Science: Positive Profit Alert
MicroPort NeuroTech Swings to H1 Loss
08:11 AM EDT, 09/28/2022 (MT Newswires) -- MicroPort NeuroTech (HKG:2172) posted an attributable loss of 92.4 million yuan ($12.8 million) in the first half of 2022, as compared to a profit of 43.8 mi
Minimally invasive brain Science: 2022 interim report
MicroPort's Neuro-interventional Device Wins Marketing Nod in Japan
09:28 AM EDT, 08/29/2022 (MT Newswires) -- MicroPort NeuroTech (HKG:2172) obtained the final regulatory approval to sell its NUMEN coil embolization system in Japan. NUMEN is an electrolytic detachme
Minimally invasive brain science: six months ended June 30, 2022 Unaudited interim results announcement
Minimally invasive brain Science: date of Board meeting
MicroPort NeuroTech's Hong Kong IPO Stabilization Ends with No Overallotment
MicroPort NeuroTech Ekes Out Slight Gain in Hong Kong Debut
10:03 PM EDT, 07/14/2022 (MT Newswires) -- MicroPort NeuroTech (HKG:2172) managed to eke out a marginal gain on its market debut in Hong Kong Friday morning. The neurointerventional device maker, whi
MicroPort NeuroTech Raises $35 Million in Xinhuanet-Backed Hong Kong IPO
10:50 PM EDT, 07/13/2022 (MT Newswires) -- MicroPort NeuroTech (HKG:2172) raised HK$278.1 million ($35.4 million) in net proceeds from its initial public offering in Hong Kong, according to a Thursday
MICROPORT NEURO (02172.HK) Oversubscribed by Over 44x; One-lot Success Rate Merely 4.88%
MICROPORT NEURO (02172.HK), a spin-off from MICROPORT (00853.HK), announced that the offer price for its Hong Kong IPO has been set at $24.64 per share. The Hong Kong public offering was oversubscribe
Loading...
No Stock Yet